• News
  • Contact
  • Login
Everyone Deserves to Be Well
Rare, for
a reason.

Read our case studies

At Atlantic Research Group, we know how difficult it is to develop an orphan drug. But, we also know that great things happen when passionate people combine their strengths. Together, we create smart, feasible studies with protocols that reflect everyday life. We connect individuals—even if there are only 50 in the entire world with a particular rare disease—to organizations that have the drive and know-how to develop potential treatments. We uncover far-reaching insights in orphan drug research, no matter how limited data may be. Let’s unite and finish the journey from trial to treatment.


YOU GIVE 100%. SO DO WE.

Dedication, dependability, and a desire to advance care through smarter clinical trials—that’s how we have enabled the successful approval of two pivotal programs in just five years and the pending approval of three more.

NORTHERA®
Chelsea Therapeutics

LEARN MORE ›
CINRYZE®
Lev Pharmaceuticals

LEARN MORE ›
Community
fuels passion and progress

The clinic isn’t the only place where we make strides. ARG works with a variety of rare disease organizations, advancing care alongside other dedicated individuals who advocate research.



"When you're fighting for a loved one with a rare disease while dealing with the stresses of life, one of the most valuable things a CRO can do is to make the clinical trial something you don't have to think about. This proactive partnership gives the sense that we're all in this together."


-Trace Brown, Board of Trustees,
Histiocytosis Association